Clinical Trial Update: High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating high-dose interval vitamin D supplementation in patients with inflammatory bowel disease receiving Remicade.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)
• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Boston Children's Hospital | Conditions: IBD, Ulcerative Colitis | Phase 3 | Status: UNKNOWN